Arena Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Global Markets Direct
April 30, 2014
36 Pages - GMD12099
$1,500.00

Summary

Global Markets Direct’s, ‘Arena Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the Arena Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Arena Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Arena Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Arena Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Arena Pharmaceuticals, Inc.’s pipeline products

Reasons to buy

- Evaluate Arena Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Arena Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Arena Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Arena Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Arena Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Arena Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

'

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Arena Pharmaceuticals, Inc. Snapshot 5
Arena Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Arena Pharmaceuticals, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Arena Pharmaceuticals, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Arena Pharmaceuticals, Inc. - Pipeline Products Glance 12
Arena Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 12
Phase I Products/Combination Treatment Modalities 12
Arena Pharmaceuticals, Inc. - Early Stage Pipeline Products 13
Discovery Products/Combination Treatment Modalities 13
Arena Pharmaceuticals, Inc. - Drug Profiles 14
APD-334 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
APD-371 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
APD-668 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
APD-811 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
temanogrel hydrochloride 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
APD-597 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Arena Pharmaceuticals, Inc. - Pipeline Analysis 21
Arena Pharmaceuticals, Inc. - Pipeline Products by Target 21
Arena Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 22
Arena Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 23
Arena Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 24
Arena Pharmaceuticals, Inc. - Recent Pipeline Updates 25
Arena Pharmaceuticals, Inc. - Dormant Projects 27
Arena Pharmaceuticals, Inc. - Discontinued Pipeline Products 28
Discontinued Pipeline Product Profiles 28
APD-597 28
nelotanserin 28
Arena Pharmaceuticals, Inc. - Company Statement 29
Arena Pharmaceuticals, Inc. - Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 36
Disclaimer 36

List of Tables
Arena Pharmaceuticals, Inc., Key Information 5
Arena Pharmaceuticals, Inc., Key Facts 5
Arena Pharmaceuticals, Inc. - Pipeline by Indication, 2014 7
Arena Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 8
Arena Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 9
Arena Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2014 10
Arena Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2014 11
Arena Pharmaceuticals, Inc. - Phase I, 2014 12
Arena Pharmaceuticals, Inc. - Discovery, 2014 13
Arena Pharmaceuticals, Inc. - Pipeline by Target, 2014 21
Arena Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 22
Arena Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 23
Arena Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 24
Arena Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 25
Arena Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 27
Arena Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2014 28
Arena Pharmaceuticals, Inc., Subsidiaries 34

List of Figures
Arena Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2014 7
Arena Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 8
Arena Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 9
Arena Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2014 21
Arena Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2014 22
Arena Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2014 23
Arena Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014 24

$1,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax